Case Report (n=1)
No
This case highlights that large left atrial thrombi can form in patients with severe mitral stenosis and atrial fibrillation despite adequate vitamin K antagonist therapy, emphasizing the need for regular echocardiographic monitoring.
Answers are grounded in this paper and cite their sources.
May support adjunctive LMWH in refractory LA thrombus; leaves open prospective trials in mitral stenosis with AF.
This case report highlights a patient with atrial fibrillation, severe mitral stenosis, and left atrial dilatation who developed a large thrombus, despite being on anticoagulant therapy. The complexity of thrombus formation in patients with multiple risk factors is described, emphasising the need for regular echocardiographic assessments to detect and monitor thrombi, even in patients undergoing anticoagulant treatment. The interplay between atrial fibrillation, mitral stenosis, and left atrial dilatation contributes to thrombus formation, requiring a multidisciplinary approach to the management of these patients. Further research is needed to improve our understanding of the optimal treatment strategies for such cases. Timely identification and intervention are critical to mitigate the risk of thromboembolic complications in these high-risk patients.
No takes yet. Share an insight, caveat, or question.
Nocco et al. (2024) conducted a case report in Atrial fibrillation and severe mitral stenosis (n=1). Warfarin was evaluated on Development of left atrial thrombus.
Synapse has enriched 10 related papers. Consider them for comparative context: